miR-429 inhibits migration and invasion of breast cancer cells in vitro

Accumulating evidence indicates that microRNAs (miRNAs) are involved in regulating cancer invasion and metastasis, and an increasing number of research demonstrates that miRNAs can promote or inhibit cell motility depending on genetic background of different cancers and the microenvironment. In the present study, we established an in vivo bone metastasis model of breast cancer by injecting MDA-MB-231 cells into the left ventricle of nude mice, and then screened the differentially expressed miRNAs between parental and bone-metastatic MDA-MB-231 cells using miRNA array. The results revealed that decreased expression of miR-429 was probably involved in negatively regulating bone metastasis of breast cancer cells. On the other hand, overexpression of miR-429 in MDA-MB-231 cells remarkably suppressed invasion in vitro. We identified ZEB1 and CRKL as potential targets of miR-429 by analyzing combined results from in silico search and global expression array of the same RNA samples. Immunoblot assay confirmed that miR-429 reduced their expression at protein level. Taken together, our results offer an opportunity for further understanding of the recondite mechanisms underlying the bone metastasis of breast cancer.

[1]  Yongwei Yu,et al.  miR‐663 Induces Castration‐Resistant Prostate Cancer Transformation and Predicts Clinical Recurrence , 2014, Journal of cellular physiology.

[2]  X Wang,et al.  Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer , 2014, Oncogene.

[3]  You-hong Cui,et al.  Primate-Specific miR-663 Functions as a Tumor Suppressor by Targeting PIK3CD and Predicts the Prognosis of Human Glioblastoma , 2014, Clinical Cancer Research.

[4]  J. Yun,et al.  miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1. , 2014, Carcinogenesis.

[5]  Yingnan Sun,et al.  miR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma , 2014, Molecular and Cellular Biochemistry.

[6]  Guoqiang Zhao,et al.  MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma , 2013, Cellular Oncology.

[7]  D. Chung,et al.  miR-335 and miR-363 regulation of neuroblastoma tumorigenesis and metastasis. , 2013, Surgery.

[8]  D. Schlaepfer,et al.  Src-inducible association of CrkL with procaspase-8 promotes cell migration , 2013, Cell adhesion & migration.

[9]  O. De Wever,et al.  miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells. , 2013, International journal of oncology.

[10]  R. Poon,et al.  Over-Expression of miR-106b Promotes Cell Migration and Metastasis in Hepatocellular Carcinoma by Activating Epithelial-Mesenchymal Transition Process , 2013, PloS one.

[11]  D. Saslow,et al.  Cancer screening in the United States, 2013 , 2013, CA: a cancer journal for clinicians.

[12]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[13]  J. Yun,et al.  MiR-663, a microRNA targeting p21WAF1/CIP1, promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma , 2012, Oncogene.

[14]  X. Zha,et al.  Bone metastasis in a novel breast cancer mouse model containing human breast and human bone , 2012, Breast Cancer Research and Treatment.

[15]  A. Pasquinelli MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship , 2012, Nature Reviews Genetics.

[16]  T. Guise,et al.  Cancer to bone: a fatal attraction , 2011, Nature Reviews Cancer.

[17]  Christopher G. Hill,et al.  Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells. , 2011, Gynecologic oncology.

[18]  Zhen Bian,et al.  miR-29b regulates migration of human breast cancer cells , 2011, Molecular and Cellular Biochemistry.

[19]  Hai Hu,et al.  Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells. , 2010, Oncology reports.

[20]  R. Kutner,et al.  Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors , 2009, Nature Protocols.

[21]  R. Weinberg,et al.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.

[22]  N. Lynam‐Lennon,et al.  The roles of microRNA in cancer and apoptosis , 2009, Biological reviews of the Cambridge Philosophical Society.

[23]  C. Schem,et al.  Increased COX2 expression enhances tumor-induced osteoclastic lesions in breast cancer bone metastasis , 2008, Clinical & Experimental Metastasis.

[24]  M. Korpal,et al.  The emerging role of miR-200 family of MicroRNAs in epithelial-mesenchymal transition and cancer metastasis , 2008, RNA biology.

[25]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[26]  J. Aubin,et al.  Breast cancer metastasis in a human bone NOD/SCID mouse model , 2007, Cancer biology & therapy.

[27]  Héctor Peinado,et al.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.

[28]  K. Livak,et al.  Real-time quantification of microRNAs by stem–loop RT–PCR , 2005, Nucleic acids research.

[29]  J. Peterse,et al.  Breast cancer metastasis: markers and models , 2005, Nature Reviews Cancer.

[30]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[31]  M. Okura,et al.  Translocation of CrkL to Focal Adhesions Mediates Integrin-Induced Migration Downstream of Src Family Kinases , 2003, Molecular and Cellular Biology.

[32]  C. Contag,et al.  Animal models of bone metastasis , 2003, Cancer.

[33]  G. Mundy Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities , 2002, Nature Reviews Cancer.

[34]  I. Fidler,et al.  Critical determinants of metastasis. , 2002, Seminars in cancer biology.

[35]  J. Griffin,et al.  The Adapter Protein Crkl Links Cbl to C3G after Integrin Ligation and Enhances Cell Migration* , 1999, The Journal of Biological Chemistry.

[36]  R. Salgia,et al.  Involvement of the adapter protein CRKL in integrin-mediated adhesion , 1999, Oncogene.

[37]  R Wieser,et al.  TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. , 1999, The Journal of clinical investigation.

[38]  C. Sawyers,et al.  The CRKL Adaptor Protein Transforms Fibroblasts and Functions in Transformation by the BCR-ABL Oncogene* , 1996, The Journal of Biological Chemistry.

[39]  T. Fioretos,et al.  Cellular interactions of CRKL, and SH2-SH3 adaptor protein. , 1994, Cancer research.

[40]  K. Kolibaba,et al.  Direct binding of CRKL to BCR-ABL is not required for BCR-ABL transformation. , 1997, Blood.